January February 2020 Global Health Matters e-newsletter

January February 2020 Global Health Matters e-newsletter

View this email as a Web page.

Global Health Matters e-newsletter from Fogarty International Center at NIH

January / February 2020

NIH mobilizes research to address new coronavirus The coronavirus outbreak that began in China in late 2019 has focused the world’s attention on how best to slow transmission, diagnose and treat those with COVID-19. At NIH, scientists are working to develop a vaccine, identify existing therapeutics and encourage coronavirus research. NIH mobilizes coronavirus research Coronavirus news and resources compiled by Fogarty
NIH, Fogarty receive funding hikes for Fiscal Year 2020 The NIH budget was approved by Congress and signed into law in December 2019, providing funding for Fiscal Year 2020. Fogarty’s allocation was boosted by 3.4 percent, bringing its total to $80.76 million. NIH, Fogarty FY2020 funding hike
Opinion: Building trust in vaccines is essential for global health Fogarty Director Dr. Roger I. Glass discusses how building trust in vaccines is essential for global health, while reflecting on the legacy of his colleague, vaccine developer Dr. Maharaj (Raj) K. Bhan, who recently passed away. Building trust in vaccines
Q and A with Dr Jean Nachega: Prioritizing research training, medical education Dr. Jean Nachega, a principal investigator on the African Forum for Research and Education in Health (AFREhealth) award, discusses the impact of the Medical Education Partnership Initiative, AFREhealth’s goals and current research priorities. Q and A with Dr Jean Nachega
Profile: Fogarty Fellow studies novel malaria detection device in Cameroon Fogarty Fellow Jillian Armstrong is working on a research project evaluating photoacoustic flow cytometry for the non-invasive detection of malaria-infected red blood cells. Profile of Jillian Armstrong
Scientist studies the moringa plant’s medicinal, nutritional benefits With Fogarty funding, Dr. Carrie Waterman helped Kenyan farmers improve cultivation and processing of the moringa plant, known for its medicinal and nutritional properties. Moringa plant’s benefits
Focus on mobile health Through its Mobile Health: Technology and Outcomes in Low and Middle Income Countries program, Fogarty has been funding projects to catalyze innovation through multidisciplinary research that addresses global health problems. Developing mobile solutions to improve health Innovative microscope enables early cancer diagnoses Scientists develop app to diagnose, treat leishmaniasis Mobile tool designed to alleviate late-stage cancer pain

Also in this issue

  • Global sepsis burden is double previous estimates
    The toll of sepsis, a life-threatening organ dysfunction due to infection, is double previous estimates, according to a recent article in The Lancet, based on data from the 2017 Global Burden of Disease study.

  • China overtaking US as global research leader
    According to the State of U.S. Science and Engineering 2020 report, U.S. scientific and engineering investment has dropped relative to the rest of the world, while spending has risen rapidly in a number of Asian countries.

  • People in the news:

    • NCI names Dr. Satish Gopal new global health director
    • Hib conjugate vaccine developer Dr. John Bennet Robbins dies
    • Global Alliance for Chronic Diseases hires Dr. Morven Roberts as CEO
    • Dr. Stephen Hahn appointed as FDA commissioner
    • Gates Foundation selects Dr. Mark Suzman as new CEO
    • AAAS picks Dr. Sudip Parikh as new CEO, executive publisher
    • Indian rotavirus vaccine developer Dr. Maharaj K. Bhan dies
    • NIH dental, craniofacial research director Dr. Martha J. Somerman retires
    • Fogarty MEPI collaborator Dr. Fitzhugh Mullan dies
    • Details: People in the news

  • Global health briefs:

    • Analysis of research in higher education released by WHO
    • Ethics issues studied for research in crises
    • CDC publishes global health security tips
    • G-FINDER report finds uneven progress on neglected diseases
    • Global Health Technologies Coalition develops new fact sheets
    • Many researchers fail to report results on ClinicalTrials.gov
    • Details: Global health briefs

E-news extras

Funding opportunities

Upcoming events

Connect with Fogarty

Facebook icon
Fogarty on Facebook |
Twitter icon
Fogarty on Twitter |
Subscribe icon
Subscribe

Global Health Matters is produced by the Office of Communications at the National Institutes of Health's Fogarty International Center . For more information, please contact managing editor Ann Puderbaugh at ann.puderbaugh@nih.gov or 301-496-2075.

Permission to reprint Global Health Matters content: All text produced in this newsletter is in the public domain and may be reprinted. Please credit Fogarty International Center. Images must be cleared for use with the individual sources, as indicated.

The Fogarty International Center, the international component of the U.S. National Institutes of Health, addresses global health challenges through innovative and collaborative research and training programs and supports and advances the NIH mission through international partnerships.

Subscribe, update your subscription or unsubscribe to this e-newsletter from the Fogarty International Center subscription page . We encourage you to forward this e-newsletter to colleagues who may find it of interest.